In regards to endorsements, the AMA and Autism groups wont be on board quickly. These associations are very big businesses and they are hardly going to endorse any new treatments which may cannablise their own authority. These large organizations are very protective of their "TURF". Mente is the new kid on the block so don't expect any warm welcomes.
Success will be driven by continuous positive feedback from those who adopt the therapy and if reality reflects the trial results, then australia will be a very big market indeed.
Assume just a 10% uptake in australia (16000 people) x $1200 profit per item = $19M profit in australia, alone, which is a relatively small market compared to Europe and the US.
NTI on 9 news Perth Tonight, page-8
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.55M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19200 | 6.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.5¢ | 50000 | 1 |
View Market Depth
| Last trade - 09.31am 26/11/2024 (20 minute delay) ? |
| NTI (ASX) Chart |
Day chart unavailable
